Oncure Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 9.00 M
- Revenue Growth -22.31%
- Profit Growth -80.96%
- Ebitda -20.13%
- Net Worth 5.99%
- Total Assets 1.93%
About Oncure Pharma
Oncure Pharma Private Limited (OPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 July 2013 and has a history of 11 years and seven months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.00 M.
Sandip Walunj, Pavan Tiwari, and Ganesh Salunke serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2013PTC245789
- Company No.
245789
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2013
- Date of AGM
30 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Oncure Pharma Private Limited offer?
Oncure Pharma Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Cardiovascular Drugs & Medication, Anaemia Medicine, Immunosuppressive Drugs, Anti Cancer Injection, Anticoagulant and Antiplatelet Drugs, Kidney Drugs, Common Disease Medicines, Injectable Products.
Who are the key members and board of directors at Oncure Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandip Walunj  | Director | 17-Jul-2013 | Current |
| Pavan Tiwari | Director | 17-Jul-2013 | Current |
| Ganesh Salunke | Director | 17-Jul-2013 | Current |
Financial Performance of Oncure Pharma.
Oncure Pharma Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 22.31% decrease. The company also saw a substantial fall in profitability, with a 80.96% decrease in profit. The company's net worth moved up by a moderate rise of 5.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oncure Pharma?
In 2017, Oncure Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹9.00 M
₹0
Charges Breakdown by Lending Institutions
- Ambarnath Jaihind Co-Op. Bank Ltd : 0.45 Cr
- Ambernath Jai-Hind Co-Op.Bank Ltd. : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Sep 2014 | Ambernath Jai-Hind Co-Op.Bank Ltd. | ₹4.50 M | Open |
| 27 Aug 2014 | Ambarnath Jaihind Co-Op. Bank Ltd | ₹4.50 M | Open |
How Many Employees Work at Oncure Pharma?
Unlock and access historical data on people associated with Oncure Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oncure Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oncure Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
